StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
19
This month
1
This year
5
Publishing Date
2024 - 04 - 11
1
2024 - 03 - 19
1
2024 - 03 - 15
1
2024 - 02 - 23
1
2024 - 01 - 02
1
2023 - 12 - 12
1
2023 - 08 - 15
1
2023 - 05 - 08
1
2022 - 11 - 21
1
2022 - 09 - 15
1
2022 - 08 - 05
1
2022 - 05 - 18
1
2022 - 04 - 01
1
2022 - 02 - 18
1
2021 - 12 - 30
1
2021 - 12 - 07
1
2021 - 12 - 06
1
2021 - 04 - 30
1
2020 - 12 - 14
1
Sector
Health technology
19
Tags
Agreement
1
Alliances
2
Application
4
Approval
3
Asco
3
Biotech
56
Biotech-bay
1
Biotech-beach
1
Biotechnology
7
Cancer
1
Car-t
11
Carvykti
7
Cel
7
Ces
1
China
1
Chmp
2
Clearance
3
Clinical hold
1
Clinical-trials-phase-iii
1
Collaboration
2
Conference
7
Corporation
3
Day
1
Direct
1
Drug
3
Earnings
9
Ema
1
Europe
2
Events
10
Expansion
1
Fda
7
Fda approval
1
Fda clearance
1
Fda-approvals
1
Financial results
5
First
1
Gene therapies
1
Gene therapy
1
Iot
16
Ipo
3
J.p. morgan healthcare conference
2
License
2
Milestone
2
N/a
2
Nasdaq
3
Offering
3
People
5
Pharm-country
19
Positive
2
Product-news
2
Regulatory
3
Report
2
Research
2
Results
17
Study
2
Submission
4
Therapeutics
2
Therapy
8
Treatment
13
Year
2
Entities
Johnson & johnson
2
Legend biotech corporation
19
Symbols
AMRN
14
AMRX
26
ANVS
16
APDN
36
ATNM
19
AVXL
12
BDX
20
BHVN
16
BMY
67
CERT
12
CTSO
12
CTXR
16
DGX
21
ECOR
19
FNCTF
22
HOTH
19
HSIC
14
ICPT
12
IMUX
15
INAB
17
INSM
21
ISEE
14
JNJ
70
KRMD
18
KRYS
12
LEGN
19
LLY
15
LUCD
17
MRK
47
MRNS
23
MS
15
NAOV
14
NRXP
21
ORMP
15
PAVM
17
PDSB
20
PFE
33
PTCT
14
PTPI
16
RCKT
15
REGN
13
RLYB
13
SCYX
12
SDGR
22
SEEL
18
SLS
16
SNGX
20
SNY
54
SNYNF
42
SONN
14
STIM
16
TEVA
19
TEVJF
18
TGTX
14
TNXP
31
TRVI
12
TRVN
16
URGN
25
VRPX
17
YMAB
22
Exchanges
Nasdaq
19
Nyse
2
Crawled Date
2024 - 04 - 11
1
2024 - 03 - 19
1
2024 - 03 - 15
1
2024 - 02 - 23
1
2024 - 01 - 02
1
2023 - 12 - 12
1
2023 - 08 - 15
1
2023 - 05 - 08
1
2022 - 11 - 21
1
2022 - 09 - 15
1
2022 - 08 - 05
1
2022 - 05 - 18
1
2022 - 04 - 01
1
2022 - 02 - 18
1
2021 - 12 - 30
1
2021 - 12 - 07
1
2021 - 12 - 06
1
2021 - 04 - 30
1
2020 - 12 - 14
1
Crawled Time
08:00
1
11:00
1
12:00
1
13:00
2
13:20
1
14:00
4
14:30
2
16:00
2
20:00
2
21:00
2
22:00
1
Source
www.biospace.com
19
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Pharm-country
symbols :
Legn
save search
Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results
Published:
2024-04-11
(Crawled : 20:00)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
-15.08%
|
O:
0.02%
H:
0.22%
C:
-0.88%
first
conference
biotech
results
Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report
Published:
2024-03-19
(Crawled : 14:00)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
-27.13%
|
O:
-1.56%
H:
0.99%
C:
-1.3%
report
biotech
publication
CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma
Published:
2024-03-15
(Crawled : 21:00)
- biospace.com/
JNJ
|
News
|
$147.17
0.98%
3.2M
|
Health Technology
|
-9.85%
|
O:
-1.58%
H:
0.0%
C:
0.0%
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
-28.72%
|
O:
-0.27%
H:
4.91%
C:
-2.9%
carvykti
fda
treatment
Legend Biotech Announces Positive CHMP Opinion for CARVYKTI® (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy
Published:
2024-02-23
(Crawled : 22:00)
- biospace.com/
JNJ
|
News
|
$147.17
0.98%
3.2M
|
Health Technology
|
-9.66%
|
O:
0.28%
H:
0.0%
C:
0.0%
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
-23.66%
|
O:
2.07%
H:
5.02%
C:
4.92%
carvykti
chmp
biotech
positive
treatment
therapy
Legend Biotech to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Published:
2024-01-02
(Crawled : 20:00)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
-21.69%
|
O:
-1.18%
H:
2.49%
C:
-0.61%
conference
biotech
Patient-Reported Outcomes from the CARTITUDE-4 Study Showed Clinically Meaningful Improvements in Health-Related Quality of Life and Reductions in Multiple Myeloma Symptoms Following Treatment with CARVYKTI® (ciltacabtagene autoleucel)
Published:
2023-12-12
(Crawled : 08:00)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
-21.45%
|
O:
0.78%
H:
3.23%
C:
2.76%
carvykti
life
treatment
study
Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
Published:
2023-08-15
(Crawled : 11:00)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
-33.02%
|
O:
-8.81%
H:
7.25%
C:
4.36%
biotech
results
Legend Biotech Corporation Announces Pricing of Registered Direct Offering of $350 Million of American Depositary Shares
Published:
2023-05-08
(Crawled : 13:00)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
-29.66%
|
O:
-2.42%
H:
5.43%
C:
5.16%
biotech
corporation
direct
offering
Legend Biotech Announces FDA Clearance of IND Application for LB2102 in Extensive Stage Small Cell Lung Cancer
Published:
2022-11-21
(Crawled : 14:00)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
-9.58%
|
O:
0.0%
H:
0.44%
C:
-2.11%
lb2102
fda
clearance
lung
biotech
application
cancer
Legend Biotech to Host 2022 R&D Day on Monday, October 3, 2022
Published:
2022-09-15
(Crawled : 13:00)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
8.35%
|
O:
-0.21%
H:
1.61%
C:
0.23%
day
biotech
Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2022
Published:
2022-08-05
(Crawled : 13:20)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
-5.8%
|
O:
0.44%
H:
0.5%
C:
-0.78%
biotech
Legend Biotech to Highlight Continued Progress in the Treatment of Multiple Myeloma With Updated Data From BCMA CAR-T Studies at 2022 ASCO and EHA
Published:
2022-05-18
(Crawled : 14:00)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
12.49%
|
O:
-2.15%
H:
2.71%
C:
-0.76%
treatment
biotech
car-t
asco
Legend Biotech Announces Appointment of Global Head of Research and Early Development
Published:
2022-04-01
(Crawled : 21:00)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
29.66%
|
O:
3.52%
H:
5.24%
C:
3.93%
research
biotech
Legend Biotech Announces Preliminary Results for the Year Ended December 31, 2021
Published:
2022-02-18
(Crawled : 14:30)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
22.23%
|
O:
0.03%
H:
2.65%
C:
-1.66%
ces
results
biotech
iot
Legend Biotech Announces Appointment of Dr. Ying Huang to the Board of Directors
Published:
2021-12-30
(Crawled : 16:00)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
-0.34%
|
O:
-0.3%
H:
5.62%
C:
5.58%
biotech
iot
Legend Biotech to Host Hybrid KOL Event Detailing CARTITUDE Data from the 63rd American Society of Hematology (ASH) Annual Meeting
Published:
2021-12-07
(Crawled : 14:00)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
3.36%
|
O:
-0.09%
H:
9.78%
C:
8.43%
ema
biotech
iot
Legend Biotech Announces Submission of New Drug Application to Japanese Regulatory Authority for BCMA CAR-T Therapy Cilta-cel for the Treatment of Relapsed or Refractory Multiple Myeloma by Janssen
Published:
2021-12-06
(Crawled : 14:30)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
6.15%
|
O:
2.7%
H:
0.0%
C:
0.0%
new drug
treatment
application
car-t
drug
therapy
biotech
iot
submission
cel
Legend Biotech Announces Submission of European Marketing Authorisation Application for BCMA CAR-T Therapy Ciltacabtagene Autoleucel (cilta-cel) for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Published:
2021-04-30
(Crawled : 12:00)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
56.49%
|
O:
-0.37%
H:
0.8%
C:
0.33%
treatment
europe
therapy
car-t
biotech
iot
submission
cel
Legend Biotech Announces FDA Clearance of the IND for LB1901, an Investigational Autologous Anti-CD4 CAR-T Therapy for Relapsed or Refractory T-Cell Lymphoma
Published:
2020-12-14
(Crawled : 16:00)
- biospace.com/
LEGN
|
$46.36
-1.61%
510K
|
Health Technology
|
67.81%
|
O:
2.1%
H:
9.14%
C:
4.64%
fda
fda clearance
biotech
therapy
car-t
t-cell
clearance
Gainers vs Losers
73%
27%
Top 10 Gainers
AGBA
|
News
|
$1.27
217.5%
120M
|
Finance
EGOX
|
$0.054
50.0%
290M
|
RWOD
|
$10.52
31.56%
5.9M
|
n/a
ZCMD
|
$1.905
31.38%
30M
|
Commercial Services
NVFY
|
$2.71
28.44%
31M
|
Consumer Durables
MRDB
4
|
$0.536
27.65%
2M
|
n/a
BSFC
|
$0.0822
27.64%
75M
|
Manufacturing
INDO
|
$5.1
25.0%
15M
|
Energy Minerals
CHRO
|
$1.53
24.9%
100K
|
n/a
AULT
|
$0.2998
23.83%
53M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.